Trump says Food and Drug Administration Commissioner Marty Makary resigned
Yasmeen Abutaleb and Ahmed Aboulenein
Reuters
Updated
Wonderwall Video
A rift between anti-abortion activists and Donald Trump has widened, highlighting internal Republican tensions over abortion policy. According to a Wall Street Journal report, movement leaders say abortion rates have risen during Trump’s tenure as abortion pills become more available. Compla…
WASHINGTON — U.S. FDA Commissioner Marty Makary resigned, President Donald Trump said Tuesday, after weeks of clashing with top White House and health advisers and drawing scrutiny for a series of controversial agency decisions, according to several people familiar with internal dynamics.
U.S. Food and Drug Administration Commissioner Marty Makary speaks at a Nov. 10 news conference at the Department of Health and Human Services in Washington, D.C.
U.S. health officials have halted the publication of several studies supporting the safety of COVID-19 and shingles vaccines, raising fresh concerns about transparency in public health policy.
U.S. President Donald Trump shakes hands with Health and Human Services Secretary Robert F. Kennedy Jr. on April 18 while Americans for Ibogaine CEO W. Bryan Hubbard, podcaster Joe Rogan and Food and Drugs Administration head Marty Makary are present for Trump's signing of an executive order about easing restrictions on mental health treatments, including, ibogaine, in the Oval Office of the White House in Washington, D.C.
What is “vape brain” — and should young people be worried? Health experts, including the Centers for Disease Control and Prevention, warn that the brain continues developing until about age 25. During this critical period, nicotine from e-cigarettes may affect attention, learning, mood and impulse control. Some experts say addiction can happen faster than many teens realize — even before vaping becomes a daily habit. In this video, we break down what “vape brain” means and why health authorities are raising concerns about vaping among young people.
U.S. Food and Drug Administration Commissioner Marty Makary speaks at a Nov. 10 news conference at the Department of Health and Human Services in Washington, D.C.
U.S. President Donald Trump shakes hands with Health and Human Services Secretary Robert F. Kennedy Jr. on April 18 while Americans for Ibogaine CEO W. Bryan Hubbard, podcaster Joe Rogan and Food and Drugs Administration head Marty Makary are present for Trump's signing of an executive order about easing restrictions on mental health treatments, including, ibogaine, in the Oval Office of the White House in Washington, D.C.
